Clinical Trials Browser

Phase NA × Postoperative Nausea and Vomiting × Electroacupuncture × Clear all

NCT07515027 2026-04-13

Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery

Phase NA Recruiting

Postoperative Nausea and Vomiting